Sign up to save your podcasts
Or
Share Interferon Gamma Signaling Drives Drug Resistance in AML
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Interferon Gamma Signaling Drives Drug Resistance in AML
Emerging research links interferon gamma signaling to drug resistance in acute myeloid leukemia, suggesting immune pathways influence relapse risk, therapy response, and future precision treatment strategies.
View all episodes
By TheBrief.HealthEmerging research links interferon gamma signaling to drug resistance in acute myeloid leukemia, suggesting immune pathways influence relapse risk, therapy response, and future precision treatment strategies.